Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Activity enhancement of the synthetic syrbactin proteasome inhibitor hybrid and biological evaluation in tumor cells.
Delivering Therapeutics to Glioblastoma: Overcoming Biological Constraints.
How patients perceive a doctor's caring attitude.
New-onset depression following stable, slow, and rapid rate of prescription opioid dose escalation.
The role of body mass in the response to growth hormone therapy.
See All 5 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Delivering Therapeutics to Glioblastoma: Overcoming Biological Constraints.
Mathew EN, Berry BC, Yang HW, Carroll RS, Johnson MD. Delivering Therapeutics to Glioblastoma: Overcoming Biological Constraints. Int J Mol Sci. 2022 Feb 02; 23(3).
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Blood-Brain Barrier
Brain Neoplasms
Drug Delivery Systems
Glioblastoma
Humans
authors with profiles
Rona Stephanie Carroll PhD
Mark Damone Johnson MD, PhD